211 related articles for article (PubMed ID: 27492324)
1. Modulation of endogenous antioxidant defense and the progression of kidney disease in multi-heritage groups of patients with type 2 diabetes: PRospective EValuation of Early Nephropathy and its Treatment (PREVENT).
Earle KA; Zitouni K; Pepe J; Karaflou M; Godbold J
J Transl Med; 2016 Aug; 14(1):234. PubMed ID: 27492324
[TBL] [Abstract][Full Text] [Related]
2. Derepression of glomerular filtration, renal blood flow and antioxidant defence in patients with type 2 diabetes at high-risk of cardiorenal disease.
Zitouni K; Steyn MRCP; Lyka E; Kelly FJ; Cook P; Ster IC; Earle KA
Free Radic Biol Med; 2020 Dec; 161():283-289. PubMed ID: 33039650
[TBL] [Abstract][Full Text] [Related]
3. The effect of hemodialysis on accelerated atherosclerosis in diabetic patients: correlation of carotid artery intima-media thickness with oxidative stress.
Dursun B; Dursun E; Suleymanlar G; Ozben B; Capraz I; Apaydin A; Ozben T
J Diabetes Complications; 2009; 23(4):257-64. PubMed ID: 18413174
[TBL] [Abstract][Full Text] [Related]
4. The Influence of the Severity of Early Chronic Kidney Disease on Oxidative Stress in Patients with and without Type 2 Diabetes Mellitus.
Andrade-Sierra J; Pazarín-Villaseñor L; Yanowsky-Escatell FG; Díaz-de la Cruz EN; García-Sánchez A; Cardona-Muñoz EG; Munguía-Galaviz FJ; de Alba-Razo A; Miranda-Díaz AG
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232497
[TBL] [Abstract][Full Text] [Related]
5. Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial).
Schutte E; Lambers Heerspink HJ; Lutgers HL; Bakker SJ; Vart P; Wolffenbuttel BH; Umanath K; Lewis JB; de Zeeuw D; Gansevoort RT
Am J Kidney Dis; 2015 Sep; 66(3):450-8. PubMed ID: 25987260
[TBL] [Abstract][Full Text] [Related]
6. Effect of addition of silymarin to renin-angiotensin system inhibitors on proteinuria in type 2 diabetic patients with overt nephropathy: a randomized, double-blind, placebo-controlled trial.
Fallahzadeh MK; Dormanesh B; Sagheb MM; Roozbeh J; Vessal G; Pakfetrat M; Daneshbod Y; Kamali-Sarvestani E; Lankarani KB
Am J Kidney Dis; 2012 Dec; 60(6):896-903. PubMed ID: 22770926
[TBL] [Abstract][Full Text] [Related]
7. Prevention of diabetic nephropathy in rats through enhanced renal antioxidative capacity by inhibition of the proteasome.
Luo ZF; Qi W; Feng B; Mu J; Zeng W; Guo YH; Pang Q; Ye ZL; Liu L; Yuan FH
Life Sci; 2011 Mar; 88(11-12):512-20. PubMed ID: 21241714
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D activates the Nrf2-Keap1 antioxidant pathway and ameliorates nephropathy in diabetic rats.
Nakai K; Fujii H; Kono K; Goto S; Kitazawa R; Kitazawa S; Hirata M; Shinohara M; Fukagawa M; Nishi S
Am J Hypertens; 2014 Apr; 27(4):586-95. PubMed ID: 24025724
[TBL] [Abstract][Full Text] [Related]
9. Glutathione peroxidase, superoxide dismutase and catalase genotypes and activities and the progression of chronic kidney disease.
Crawford A; Fassett RG; Coombes JS; Kunde DA; Ahuja KD; Robertson IK; Ball MJ; Geraghty DP
Nephrol Dial Transplant; 2011 Sep; 26(9):2806-13. PubMed ID: 21325350
[TBL] [Abstract][Full Text] [Related]
10. Effects of Silybum marianum (L.) Gaertn. (silymarin) extract supplementation on antioxidant status and hs-CRP in patients with type 2 diabetes mellitus: a randomized, triple-blind, placebo-controlled clinical trial.
Ebrahimpour Koujan S; Gargari BP; Mobasseri M; Valizadeh H; Asghari-Jafarabadi M
Phytomedicine; 2015 Feb; 22(2):290-6. PubMed ID: 25765835
[TBL] [Abstract][Full Text] [Related]
11. Association between plasma soluble RAGE and renal function is unaffected by medication usage and enzymatic antioxidants in chronic kidney disease with type 2 diabetes.
Wong FN; Tan JA; Keng TC; Ng KP; Chua KH; Kuppusamy UR
Clin Chim Acta; 2016 Jan; 453():56-61. PubMed ID: 26657980
[TBL] [Abstract][Full Text] [Related]
12. Kolaviron, a biflavonoid complex of Garcinia kola seeds modulates apoptosis by suppressing oxidative stress and inflammation in diabetes-induced nephrotoxic rats.
Ayepola OR; Cerf ME; Brooks NL; Oguntibeju OO
Phytomedicine; 2014 Dec; 21(14):1785-93. PubMed ID: 25481391
[TBL] [Abstract][Full Text] [Related]
13. Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetic patients.
Likidlilid A; Patchanans N; Peerapatdit T; Sriratanasathavorn C
J Med Assoc Thai; 2010 Jun; 93(6):682-93. PubMed ID: 20572373
[TBL] [Abstract][Full Text] [Related]
14. Kidney Disease End Points in a Pooled Analysis of Individual Patient-Level Data From a Large Clinical Trials Program of the Dipeptidyl Peptidase 4 Inhibitor Linagliptin in Type 2 Diabetes.
Cooper ME; Perkovic V; McGill JB; Groop PH; Wanner C; Rosenstock J; Hehnke U; Woerle HJ; von Eynatten M
Am J Kidney Dis; 2015 Sep; 66(3):441-9. PubMed ID: 25960304
[TBL] [Abstract][Full Text] [Related]
15. Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction: a single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controls.
Neri S; Signorelli SS; Torrisi B; Pulvirenti D; Mauceri B; Abate G; Ignaccolo L; Bordonaro F; Cilio D; Calvagno S; Leotta C
Clin Ther; 2005 Nov; 27(11):1764-73. PubMed ID: 16368447
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of apoptosis and modulation of TGF-β1 by sodium selenate prevents streptozotocin-induced diabetic rat renal impairment.
Roy S; Dontamalla SK; Mondru AK; Sannigrahi S; Veerareddy PR
Biol Trace Elem Res; 2011 Jan; 139(1):55-71. PubMed ID: 20174975
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effect of succinic acid monoethyl ester on erythrocyte membrane bound enzymes and antioxidant status in streptozotocin-nicotinamide induced type 2 diabetes.
Pari L; Saravanan R
Chem Biol Interact; 2007 Aug; 169(1):15-24. PubMed ID: 17537413
[TBL] [Abstract][Full Text] [Related]
18. Effect of aspirin on renal disease progression in patients with type 2 diabetes: A multicenter, double-blind, placebo-controlled, randomized trial. The renaL disEase progression by aspirin in diabetic pAtients (LEDA) trial. Rationale and study design.
Violi F; Targher G; Vestri A; Carnevale R; Averna M; Farcomeni A; Lenzi A; Angelico F; Cipollone F; Pastori D
Am Heart J; 2017 Jul; 189():120-127. PubMed ID: 28625368
[TBL] [Abstract][Full Text] [Related]
19. Serum bisphenol A and progression of type 2 diabetic nephropathy: a 6-year prospective study.
Hu J; Yang S; Wang Y; Goswami R; Peng C; Gao R; Zhou H; Zhang Y; Cheng Q; Zhen Q; Li Q
Acta Diabetol; 2015 Dec; 52(6):1135-41. PubMed ID: 26321107
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of omega-3 and vitamin E coadministration on gene expression of SIRT1 and PGC1α and serum antioxidant enzymes in patients with coronary artery disease.
Saboori S; Koohdani F; Nematipour E; Yousefi Rad E; Saboor-Yaraghi AA; Javanbakht MH; Eshraghian MR; Ramezani A; Djalali M
Nutr Metab Cardiovasc Dis; 2016 Jun; 26(6):489-94. PubMed ID: 27033026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
